Blog / Specialty

Spine in the ASC: Which Procedures, Which Payers and What Margin

What the 2026 covered-list expansion means for spine case selection, implant cost and payer contracts.

ASC spine economics after the 2026 rule: covered codes, implant cost share, and how to price a spine case before adding it.

Spine in the ASC: Which Procedures, Which Payers and What Margin

ASC spine programs are the clearest test of whether a center can turn the 2026 covered procedures list into margin, not just volume. CMS added 560 procedures and 35 ancillary services to the ASC list for 2026, and 271 of those came from the phase-out of the inpatient only list, with musculoskeletal procedures moved first under a new Level 7 payment classification (CMS, November 2025). Spine is the specialty where that decision matters most, because spine already carries the highest supply cost of any specialty line in the ASC.

A code moving onto the covered list is not the same as a code that pays enough to cover an implant and a room. Before a surgeon schedules the first spine case under the new list, the center needs the payment number, the implant cost, and the payer's actual rate, in that order.

What changed for spine in the 2026 rule

The rule did four things that touch spine directly: it raised the base ASC payment update, it expanded the covered list through the inpatient only phase-out, it created a new musculoskeletal payment classification, and it widened site neutrality for drug administration in hospital outpatient departments. None of the four tells you what a specific spine procedure nets after implant cost, but together they explain why spine volume is moving toward ASCs faster than most other specialties right now.

What the CY2026 Medicare ASC rule changed for spine (CMS, November 2025)
ItemWhat it means for spine
Payment updateASC and hospital outpatient rates rose about 2.6% for centers meeting quality reporting requirements.
Covered procedures list560 procedures and 35 ancillary services added; 271 of them removed from the inpatient only list.
Inpatient only phase-outMusculoskeletal procedures went first, with a new Level 7 musculoskeletal payment classification created for them.
Quality reporting penaltyCenters that miss ASC Quality Reporting requirements lose 2.0 percentage points off the annual payment update.
Site neutralityExpanded for drug administration services in excepted off-campus hospital departments, paid at the physician fee schedule rate instead of the hospital rate.

The inpatient only phase-out runs three years, and musculoskeletal went first. That means more spine codes are likely to move in the next two rule cycles. Check the CY2027 final rule, published this November, before you build a 2027 spine pro forma on the 2026 list. See ASC vs HOPD: How Reimbursement Differs for the Most Common Procedures for how the same code prices differently by site of service, which is the comparison that matters when a surgeon asks why a case should move.

The margin math behind an ASC spine case

Across all specialties, supplies take about 26.4% of net revenue at the median center and climb to 36.8% at the 90th percentile (Avanza, 2022). Spine and orthopedics sit at the high end of that range, running near 30% of revenue because of implants, against 12 to 15% for GI and ophthalmology cases that carry no hardware. That gap is almost entirely the implant line, not the rest of the supply cart.

The case costing method we use with centers starts from collections, not the preference card:

  1. Net revenue per case, by procedure code and by payer, from the billing system.
  2. Actual consumption, counted at the end of the case, not what the preference card lists.
  3. Implants priced per case from the invoice. For spine this is the single largest line and the one most centers do not track case by case.
  4. Labor loaded by minutes in the room, at the loaded hourly rate.
  5. Room time and overhead spread per scheduled OR minute.

SIS benchmark ratios applied to an illustrative $2,000 case put drugs and supplies at $432 (21.6% of collections) and staff labor at $470 (23.5% of collections), before any implant cost is added (SIS, 2019). On a spine case, the implant line alone can equal or exceed both of those combined. A new musculoskeletal code with no implant cost attached to the pro forma is not a margin number, it is a guess. For the full specialty comparison, including where ophthalmology and GI sit against spine, see Supply Cost per Case by Specialty: Orthopedics, GI, Ophthalmology and Spine.

Our Case Costing for Surgery Centers method applies this at the code and surgeon level, which is the resolution a spine decision needs. A center deciding whether to add a newly covered fusion code should run it through the same five steps before the first case is scheduled, not after a quarter of volume shows up on the P&L as a surprise.

Payer contracting for spine implants

Most commercial payers price ASC procedures as a multiple of the Medicare rate. A code that moved onto the covered list in 2026 may have no commercial rate attached at all, which means the first spine case under a new code is a negotiation, not a payment. Centers that walk into that conversation with cost per case data, not a rate sheet, are the ones asking for the right thing.

For spine specifically, the ask that matters most is an implant carve-out: payment at invoice plus a handling percentage, separate from the base procedure rate. A blanket percentage of Medicare does not account for the fact that one surgeon's cage costs $1,800 and another's costs $3,400 for the same procedure code. Without a carve-out, the center absorbs that spread regardless of which surgeon is in the room.

Three things to bring to a spine payer conversation:

  • Contribution margin by procedure and by payer, from the case costing method above, showing which spine codes are under water at the current rate.
  • Volume by payer for the past 12 months, plus the new covered codes your spine surgeons intend to perform.
  • The same-procedure cost comparison against the hospital outpatient department, since Medicare and most commercial payers already pay less in the ASC setting, and site neutrality is pulling hospital rates down further.

Management companies that bring spine programs into a center commonly charge a management fee in the range of 4 to 7% of net revenue, in addition to an equity stake, and that fee comes out before the implant carve-out helps the center. Model it before signing, not after the first quarterly distribution.

Building the spine pro forma, not the average one

A spine pro forma built on the Avanza EBITDA benchmark, 12.8% under $3 million of revenue and 37.3% above $9 million, tells you the spread exists but not which side of it a new spine line lands on (Avanza). The pro forma that survives is built on the contribution margin of the specific codes the surgeons will perform, priced against the payer mix the center can actually sign, with implants costed per invoice rather than per preference card.

Certificate of need rules apply in 35 states plus the District of Columbia, and several exempt ASCs or use lighter review for added capacity (AHPA/NCSL, 2025). A spine expansion that adds rooms, not just cases to existing rooms, needs that check before the feasibility study, not during it.

If the center already tracks the ten benchmarks from case volume to EBITDA margin, adding spine is a question of whether the new codes clear the same bar as the existing case mix. If those numbers are not tracked monthly, spine is the wrong specialty to find that out the hard way, since it carries the highest supply cost exposure in the building. For the margin targets a spine-heavy case mix should be measured against, see ASC EBITDA Margins: What a Healthy Center Earns and Where the Leaks Are.

What to do this quarter

  1. Pull every spine code your surgeons performed in the hospital in the past 12 months and check it against the 2026 covered procedures list, then confirm the CY2027 update before budgeting any of them.
  2. Cost your current spine cases by implant invoice, not preference card, and rank them by contribution margin, by surgeon and by payer.
  3. Take the bottom three spine codes by margin to the payer that sends the most volume and ask for an implant carve-out at invoice plus handling, backed by the cost data from step two.

Make your ASC more profitable

Sigmatic is a team of ASC consultants who use our own technology to manage surgery centers: better margins, better workflows, and a real-time view of cost per case and utilization that keeps the gains in place. If the numbers in this article look like your center, book a free 30-minute consultation and we will go through your own figures and show you where the margin is. Read the Case Costing for Surgery Centers guide, grab the free PDF, The 2027 ASC State of the Union: maximizing profit on razor-thin margins, from the form on this page, or email [email protected].

Free guide

The 2027 ASC State of the Union: Maximizing profit on razor-thin margins

16 pages of charts: the market, the 2026 reimbursement rules, the benchmarks that separate a 13 percent margin from a 37 percent one, a case costing method you can run this month and a 90-day plan.

One email with the PDF, then the occasional note on ASC margins. Unsubscribe any time.

Before you go

Want a more profitable ASC?

Book a free 30-minute consultation on your own numbers, or leave your email and we will send the 2027 guide first.

Make your ASC more profitable.

A free 30-minute consultation on your own numbers: where the margin is, what to fix first. No obligation.